Breast Reconstruction Surgery Rates and Regional Differences in Japan (2025)

Breast Reconstruction Rates by Region in Japan (2025)

Sources: Japan Breast Cancer Society – Reconstruction Working Group (2022–2024), J-STAGE: Trends and Challenges in Breast Reconstruction (2024), Ministry of Health, Labour and Welfare – NDB Open Data (2025)

Introduction

Following mastectomy for breast cancer, an increasing number of patients in Japan are considering breast reconstruction. However, the overall rate of reconstruction surgery remains low, and there are significant regional disparities. This article presents the latest data from 2025 using public sources, visualized in a chart, and explores the background and challenges surrounding breast reconstruction in Japan.

Breast Reconstruction Rates (2025)

According to data from the Ministry of Health, Labour and Welfare (NDB Open Data) and academic reports, the national average rate of breast reconstruction after mastectomy in Japan is 12.5%.
Regional breakdowns show notable differences:

  • Tokyo: 26% (highest)
  • Osaka: 18%
  • **Kanagawa: 15%
  • Aichi: 14%
  • Fukuoka: 10%
  • Hiroshima: 9%
  • Hokkaido: 7%
  • Okinawa: 5%
  • Tottori: 3% (lowest)

These figures highlight a clear urban–rural gap in access and uptake.

Factors Behind Regional Disparities

Several factors contribute to the low and uneven rates of breast reconstruction:

  • Uneven distribution of plastic and reconstructive surgeons
  • Limited access to information about reconstruction options
  • Financial and time burdens associated with surgery
  • Cultural and psychological barriers to reconstruction

Organizations such as the Japan Breast Cancer Society are working to improve awareness and reduce disparities across regions.

Conclusion

While breast reconstruction is not a life-saving procedure, it can significantly impact quality of life (QOL) and self-image after treatment. Ensuring that all patients have access to accurate information and fair choices remains an important goal.

Note: This website is not a medical institution. For medical decisions or treatment options, please consult a qualified healthcare provider.

Sources

Sources: Japan Breast Cancer Society – Reconstruction Working Group (2022–2024), J-STAGE: Trends and Challenges in Breast Reconstruction (2024), Ministry of Health, Labour and Welfare – NDB Open Data (2025)